{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:05:52Z","timestamp":1789621552501,"version":"build-2803163510"},"reference-count":172,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>MIS-C is a newly defined post-viral myocarditis and inflammatory vasculopathy of children following COVID-19 infection. This review summarizes the literature on diagnosis, parameters of disease severity, and current treatment regimens. The clinical perspective was analyzed in light of potential immunopathogenesis and compared to other post-infectious and inflammatory illnesses of children affecting the heart. In this paradigm, the evidence supports the importance of endothelial injury and activation of the IL-1 pathway as a common determinant among MIS-C, Kawasaki disease, and Acute Rheumatic fever.<\/jats:p>","DOI":"10.3389\/fped.2020.626182","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T08:05:45Z","timestamp":1610265945000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":152,"title":["Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis\u2014A Critical Review of Its Pathogenesis and Treatment"],"prefix":"10.3389","volume":"8","author":[{"given":"Jeremy C.","family":"McMurray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine W.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olcay Y.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"B1","unstructured":"Coronavirus Disease 2019 (COVID-19) Situation Report \u2013 942020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/jmv.25807","article-title":"COVID-19 epidemic: disease characteristics in children","volume":"92","author":"She","year":"2020","journal-title":"J Med Virol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/apa.15271","article-title":"Why is COVID-19 so mild in children?","volume":"109","author":"Brodin","year":"2020","journal-title":"Acta Paediatr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","article-title":"A review of coronavirus disease-2019 (COVID-19)","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian J Pediatr."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.ccc039.","article-title":"New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response","author":"Panupattanapong","year":"2020","journal-title":"Cleve Clin J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpeds.2020.06.044","article-title":"Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS-CoV-2 infection","volume":"224","author":"Capone","year":"2020","journal-title":"J Pediatr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2246.e3","DOI":"10.1016\/j.ajem.2020.05.058","article-title":"Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department","volume":"38","author":"Waltuch","year":"2020","journal-title":"Am J Emerg Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13613-020-00690-8","article-title":"Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children","volume":"10","author":"Grimaud","year":"2020","journal-title":"Ann Intensive Care."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2001010","DOI":"10.2807\/1560-7917.ES.2020.25.22.2001010","article-title":"SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020","volume":"25","author":"Belot","year":"2020","journal-title":"Euro Surveill."},{"key":"B10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/jpids\/piaa062","article-title":"Pediatric COVID-associated multi-system inflammatory syndrome (PMIS)","volume":"9","author":"Shulman","year":"2020","journal-title":"J Pediatric Infect Dis Soc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.120.048360","article-title":"Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic","volume":"142","author":"Belhadjer","year":"2020","journal-title":"Circulation."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa087.","article-title":"Systemic inflammation with cardiac involvement in pediatric patients with evidence of COVID-19 in a community hospital in the Bronx, NY","author":"Rogo","year":"2020","journal-title":"J Pediatric Infect Dis Soc."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.15048.","article-title":"Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran","author":"Bahrami","year":"2020","journal-title":"J Paediatr Child Health."},{"key":"B14","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","article-title":"Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study","volume":"369","author":"Toubiana","year":"2020","journal-title":"BMJ."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1093\/eurheartj\/ehaa536","article-title":"Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology","volume":"41","author":"Wacker","year":"2020","journal-title":"Eur Heart J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2352-4642(20)30164-4","article-title":"Septic shock presentation in adolescents with COVID-19","volume":"4","author":"Dallan","year":"2020","journal-title":"Lancet Child Adolesc Health."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e20201711","DOI":"10.1542\/peds.2020-1711","article-title":"SARS-CoV-2-Induced kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children","volume":"146","author":"Licciardi","year":"2020","journal-title":"Pediatrics."},{"key":"B18","doi-asserted-by":"publisher","first-page":"202288","DOI":"10.1148\/radiol.2020202288","article-title":"Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) assocsiated with COVID-19: case series","volume":"2020","author":"Blondiaux","year":"2020","journal-title":"Radiology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.04.20142752.","article-title":"Mapping systemic inflammation and antibody responses in Multisystem Inflammatory Syndrome in Children (MIS-C)","author":"Gruber","year":"2020","journal-title":"medRxiv."},{"key":"B20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpeds.2020.06.045","article-title":"Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection: a multi-institutional study from New York city","volume":"224","author":"Kaushik","year":"2020","journal-title":"J Pediatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1053\/j.gastro.2020.05.079","article-title":"Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases","volume":"159","author":"Miller","year":"2020","journal-title":"Gastroenterology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"JAMA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10374","article-title":"Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York city","volume":"324","author":"Cheung","year":"2020","journal-title":"JAMA."},{"key":"B24","unstructured":"Case Definition for MIS-C2020"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.jmb.2020.04.009","article-title":"Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop","volume":"432","author":"Jaimes","year":"2020","journal-title":"J Mol Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The severe acute respiratory syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N Engl J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.5144\/0256-4947.2013.427","article-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV): a perpetual challenge","volume":"33","author":"Hajjar","year":"2013","journal-title":"Ann Saudi Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/01.inf.0000247136.28950.41","article-title":"Severe acute respiratory syndrome in children","volume":"26","author":"Stockman","year":"2007","journal-title":"Pediatr Infect Dis J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.15537\/smj.2015.4.10243","article-title":"Middle East respiratory syndrome coronavirus in children","volume":"36","author":"Thabet","year":"2015","journal-title":"Saudi Med J."},{"key":"B30","unstructured":"Coronavirus disease (COVID-19)? Weekly Epidemiological Update Geneva"},{"key":"B31","unstructured":"Coronavirus Disease 2019 (COVID-19): Information for Pediatric Healthcare Providers2020"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics."},{"key":"B33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature."},{"key":"B34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"Lu","year":"2013","journal-title":"Nature."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2000062","DOI":"10.2807\/1560-7917.ES.2020.25.5.2000062","article-title":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020","volume":"25","author":"Backer","year":"2020","journal-title":"Euro Surveill."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S2213-2600(20)30354-4","article-title":"SARS-CoV-2 viral load predicts COVID-19 mortality","volume":"8","author":"Pujadas","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1044","article-title":"Systematic SARS-CoV-2 screening at hospital admission in children:a French prospective multicenter study","author":"Poline","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jpeds.2020.08.037","article-title":"Pediatric SARS-CoV-2: clinical presentation, infectivity, and immune responses","volume":"227","author":"Yonker","year":"2020","journal-title":"J Pediatr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1001\/jamapediatrics.2020.3651","article-title":"Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19)","volume":"174","author":"Heald-Sargent","year":"2020","journal-title":"JAMA Pediatr"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamadermatol.2020.2062","article-title":"Focus on \u201cCOVID Toes\u201d","volume":"156","author":"Hernandez","year":"2020","journal-title":"JAMA Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bjd.19327","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1161\/CIRCULATIONAHA.108.766022","article-title":"Viral myocarditis: from the perspective of the virus","volume":"119","author":"Yajima","year":"2009","journal-title":"Circulation."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4065\/84.11.1001","article-title":"Diagnosis and treatment of viral myocarditis","volume":"84","author":"Schultz","year":"2009","journal-title":"Mayo Clin Proc."},{"key":"B46","doi-asserted-by":"publisher","first-page":"8234","DOI":"10.4049\/jimmunol.177.11.8234","article-title":"Mimicry and antibody-mediated cell signaling in autoimmune myocarditis","volume":"177","author":"Li","year":"2006","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3851\/IMP1563","article-title":"Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy","volume":"15","author":"Dennert","year":"2010","journal-title":"Antivir Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1073\/pnas.89.1.314","article-title":"Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation","volume":"89","author":"Klingel","year":"1992","journal-title":"Proc Natl Acad Sci USA."},{"key":"B49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1161\/01.RES.74.2.182","article-title":"Viral infection and the pathogenesis of dilated cardiomyopathy","volume":"74","author":"Martino","year":"1994","journal-title":"Circ Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fcvm.2019.00048","article-title":"Cardio-immunology of myocarditis: focus on immune mechanisms and treatment options","volume":"6","author":"Maisch","year":"2019","journal-title":"Front Cardiovasc Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e003293","DOI":"10.1161\/JAHA.112.003293","article-title":"Successful use of mRNA-nucleofection for overexpression of interleukin-10 in murine monocytes\/macrophages for anti-inflammatory therapy in a murine model of autoimmune myocarditis","volume":"1","author":"Zimmermann","year":"2012","journal-title":"J Am Heart Assoc."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e85851","DOI":"10.1172\/jci.insight.85851","article-title":"Cardiac myosin-Th17 responses promote heart failure in human myocarditis","volume":"1","author":"Myers","year":"2016","journal-title":"JCI Insight"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1073\/pnas.89.4.1320","article-title":"Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin","volume":"89","author":"Cunningham","year":"1992","journal-title":"Proc Natl Acad Sci USA."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3892\/etm.2014.1671","article-title":"Combined electrocardiography, coronary angiography and magnetic resonance imaging for the diagnosis of viral myocarditis: a case report","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp Ther Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ijcard.2016.12.103","article-title":"Biventricular endomyocardial biopsy in patients with suspected myocarditis: feasibility, complication rate and additional diagnostic value","volume":"230","author":"Stiermaier","year":"2017","journal-title":"Int J Cardiol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.4916","article-title":"Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection","author":"Rajpal","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.2217\/fca-2020-0082.","article-title":"Sudden cardiac death in COVID-19 patients, a report of three cases","author":"Shirazi","year":"2020","journal-title":"Future Cardiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00059-020-04924-0","article-title":"Arrhythmias and sudden cardiac death in the COVID-19 pandemic","volume":"45","author":"Kuck","year":"2020","journal-title":"Herz."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ihj.2020.10.001","article-title":"COVID-19 and sudden cardiac death: a new potential risk","volume":"72","author":"Yadav","year":"2020","journal-title":"Indian Heart J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3899\/jrheum.200334","article-title":"The rheumatologist's role in COVID-19","volume":"47","author":"Cron","year":"2020","journal-title":"J Rheumatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.autrev.2007.11.010","article-title":"Genetic complexity of autoimmune myocarditis","volume":"7","author":"Li","year":"2008","journal-title":"Autoimmun Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1113\/JP270597","article-title":"Arterial structure and function in vascular ageing: are you as old as your arteries?","volume":"594","author":"Thijssen","year":"2016","journal-title":"J Physiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.15585\/mmwr.mm6940e1","article-title":"Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March-August 2020","volume":"69","author":"Morris","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archinte.1929.00130240004001","article-title":"Aneurysm of the coronary arteries","volume":"43","author":"Packard","year":"1929","journal-title":"Arch Inter Med."},{"key":"B66","unstructured":"33131972Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States2020"},{"key":"B67","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.JAA.0000668792.41976.f2","article-title":"Kawasaki disease: shedding light on a mysterious diagnosis","volume":"33","author":"Galuppo","year":"2020","journal-title":"JAAPA."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.jacc.2015.12.073","article-title":"Kawasaki disease","volume":"67","author":"Newburger","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41577-020-0367-5","article-title":"Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children","volume":"20","author":"Rowley","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","article-title":"Autoimmune and inflammatory diseases following COVID-19","volume":"16","author":"Galeotti","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.5114\/amsad.2018.74522","article-title":"Kawasaki disease: a comprehensive review","volume":"3","author":"Ramphul","year":"2018","journal-title":"Arch Med Sci Atheroscler Dis."},{"key":"B72","unstructured":"Infographic: Early Cases of MIS-C: Multi-System Inflammatory Syndrome in U.S. Children 2020"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.jacc.2020.08.056","article-title":"Echocardiographic findings in pediatric multisystem inflammatory syndrome associated with COVID-19 in the United States","volume":"76","author":"Matsubara","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S2352-4642(20)30168-1","article-title":"Acute myocardial injury: a novel clinical pattern in children with COVID-19","volume":"4","author":"Wolfler","year":"2020","journal-title":"Lancet Child Adolesc Health."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-018-0303-4","article-title":"Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN- \u03b3 as biomarkers for early recognition","volume":"17","author":"Li","year":"2019","journal-title":"Pediatr Rheumatol Online J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/00148581-200507010-00002","article-title":"Toxic shock syndrome in children: epidemiology, pathogenesis, and management","volume":"7","author":"Chuang","year":"2005","journal-title":"Paediatr Drugs."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3201\/eid2606.190783","article-title":"Manifestations of toxic shock syndrome in children, Columbus, Ohio, USA, 2010-2017(1)","volume":"26","author":"Cook","year":"2020","journal-title":"Emerg Infect Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5114\/reum.2018.74748","article-title":"Rheumatic fever - new diagnostic criteria","volume":"56","author":"Szczygielska","year":"2018","journal-title":"Reumatologia."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1161\/01.CIR.88.5.2198","article-title":"Does endomyocardial biopsy aid in the diagnosis of active rheumatic carditis?","volume":"88","author":"Narula","year":"1993","journal-title":"Circulation."},{"key":"B81","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0195-668X(02)00825-4","article-title":"Does rheumatic myocarditis really exists? Systematic study with echocardiography and cardiac troponin I blood levels","volume":"24","author":"Kamblock","year":"2003","journal-title":"Eur Heart J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0002-9149(01)02358-X","article-title":"Serum cardiac troponin I in acute rheumatic fever","volume":"89","author":"Gupta","year":"2002","journal-title":"Am J Cardiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/0974-2069.99621","article-title":"Rheumatic fever pathogenesis: approach in research needs change","volume":"5","author":"Tandon","year":"2012","journal-title":"Ann Pediatr Cardiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1172\/JCI7132","article-title":"Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin","volume":"106","author":"Galvin","year":"2000","journal-title":"J Clin Invest."},{"key":"B85","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/318076","article-title":"Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium","volume":"183","author":"Roberts","year":"2001","journal-title":"J Infect Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jfma.2013.12.008","article-title":"Viral infections associated with Kawasaki disease","volume":"113","author":"Chang","year":"2014","journal-title":"J Formos Med Assoc."},{"key":"B87","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/1744666X.2017.1232165","article-title":"Kawasaki disease: etiopathogenesis and novel treatment strategies","volume":"13","author":"Agarwal","year":"2017","journal-title":"Expert Rev Clin Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e760","DOI":"10.1542\/peds.2005-0559","article-title":"Infections and Kawasaki disease: implications for coronary artery outcome","volume":"116","author":"Benseler","year":"2005","journal-title":"Pediatrics."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/S0140-6736(89)91910-7","article-title":"Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease","volume":"2","author":"Leung","year":"1989","journal-title":"Lancet."},{"key":"B90","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4161\/viru.26482","article-title":"Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock","volume":"5","author":"De Backer","year":"2014","journal-title":"Virulence."},{"key":"B91","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00024382-199702000-00006","article-title":"Endothelial structural integrity is maintained during endotoxic shock in an interleukin-1 type 1 receptor knockout mouse","volume":"7","author":"Sutton","year":"1997","journal-title":"Shock."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e00848","DOI":"10.1128\/IAI.00848-17","article-title":"The superantigen toxic shock syndrome toxin 1 alters human aortic endothelial cell function","volume":"86","author":"Kulhankova","year":"2018","journal-title":"Infect Immun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/ATVBAHA.115.306475","article-title":"IL-1 signaling is critically required in stromal cells in kawasaki disease vasculitis mouse model: role of both IL-1\u03b1 and IL-1\u03b2","volume":"35","author":"Lee","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12519-020-00354-4","article-title":"Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study","volume":"16","author":"Sun","year":"2020","journal-title":"World J Pediatr."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.21.109272.","article-title":"An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations","author":"Cheng","year":"2020","journal-title":"bioRxiv."},{"key":"B96","unstructured":"Multisystem inflammatory syndrome in children (MIS-C): the role of viral superantigens in COVID-19 disease1820 BittmannSW LuchterE Mosch\u00fcring-AlievaE VillalonG J Allergy Infect Dis12020"},{"key":"B97","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4049\/jimmunol.163.2.1060","article-title":"Anti-human cardiac myosin autoantibodies in Kawasaki syndrome","volume":"163","author":"Cunningham","year":"1999","journal-title":"J Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev."},{"key":"B100","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fimmu.2019.00360","article-title":"Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis","volume":"10","author":"Gaudino","year":"2019","journal-title":"Front Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e3501","DOI":"10.1097\/MD.0000000000003501","article-title":"Interferon-gamma genetic polymorphism and expression in Kawasaki disease","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3389\/fimmu.2018.02974","article-title":"How should we classify Kawasaki disease?","volume":"9","author":"Marrani","year":"2018","journal-title":"Front Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fphar.2017.00163","article-title":"IL-1 inhibition may have an important role in treating refractory Kawasaki disease","volume":"8","author":"Dusser","year":"2017","journal-title":"Front Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.imlet.2020.06.013","article-title":"Lymphopenia during the COVID-19 infection: what it shows and what can be learned","volume":"225","author":"Tavakolpour","year":"2020","journal-title":"Immunol Lett."},{"key":"B105","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11926-011-0165-y","article-title":"Current status of understanding the pathogenesis and management of patients with NOMID\/CINCA","volume":"13","author":"Goldbach-Mansky","year":"2011","journal-title":"Curr Rheumatol Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jcma.2013.04.005","article-title":"Interleukin-18 and coronary artery lesions in patients with Kawasaki disease","volume":"76","author":"Weng","year":"2013","journal-title":"J Chin Med Assoc."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ng.2220","article-title":"A genome-wide association study identifies three new risk loci for Kawasaki disease","volume":"44","author":"Onouchi","year":"2012","journal-title":"Nat Genet."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e113054","DOI":"10.1371\/journal.pone.0113054","article-title":"Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms","volume":"9","author":"Kusuda","year":"2014","journal-title":"PLoS ONE."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41564-017-0005-6","article-title":"Group A streptococcal M protein activates the NLRP3 inflammasome","volume":"2","author":"Valderrama","year":"2017","journal-title":"Nat Microbiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin Microbiol Rev."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15512.","article-title":"Kawasaki syndrome: role of superantigens revisited","author":"Leung","year":"2020","journal-title":"FEBS J."},{"key":"B114","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/intimm\/dxg007","article-title":"Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease","volume":"15","author":"Duong","year":"2003","journal-title":"Int Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1172\/JCI111334","article-title":"Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome","volume":"73","author":"Ikejima","year":"1984","journal-title":"J Clin Invest."},{"key":"B116","doi-asserted-by":"publisher","first-page":"S316","DOI":"10.1093\/clinids\/11.Supplement_1.S316","article-title":"Toxic shock syndrome is mediated by interleukin 1 and tumor necrosis factor","volume":"11","author":"Ikejima","year":"1989","journal-title":"Rev Infect Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1442-200x.2005.02049.x","article-title":"Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease","volume":"47","author":"Takahashi","year":"2005","journal-title":"Pediatr Int."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1016\/S2665-9913(20)30137-5","article-title":"Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms","volume":"2","author":"Pain","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e002365","DOI":"10.1161\/CIRCGEN.118.002365","article-title":"HLA-B*54:01 is associated with susceptibility to Kawasaki disease","volume":"12","author":"Kwon","year":"2019","journal-title":"Circ Genom Precis Med."},{"key":"B120","unstructured":"Characterisation of immune complexes in Kawasaki disease and other infectious diseases by protein sequencing182 MenikouS McArdleA KaforouM ShimizuC WrightVJ HerbergJA J Immunol.2022019"},{"key":"B121","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fcvm.2020.00094","article-title":"Antibodies and immunity during Kawasaki disease","volume":"7","author":"Hicar","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.4049\/jimmunol.166.2.1334","article-title":"Oligoclonal IgA response in the vascular wall in acute Kawasaki disease","volume":"166","author":"Rowley","year":"2001","journal-title":"J Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41591-020-0817-4","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","author":"Xu","year":"2020","journal-title":"Nat Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","article-title":"Cardiac autoimmunity: myocarditis","volume":"1003","author":"Bracamonte-Baran","year":"2017","journal-title":"Adv Exp Med Biol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jaut.2009.09.005","article-title":"Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice","volume":"33","author":"Taneja","year":"2009","journal-title":"J Autoimmun."},{"key":"B127","doi-asserted-by":"publisher","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"B128","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4049\/jimmunol.0800861","article-title":"Cutting edge: cardiac myosin activates innate immune responses through TLRs","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e20164096","DOI":"10.1542\/peds.2016-4096","article-title":"When lightning strikes twice in pediatrics: case report and review of recurrent myocarditis","volume":"141","author":"Floyd","year":"2018","journal-title":"Pediatrics."},{"key":"B130","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/08916930802031579","article-title":"Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies","volume":"41","author":"Mascaro-Blanco","year":"2008","journal-title":"Autoimmunity."},{"key":"B131","first-page":"499","article-title":"Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy","volume":"116","author":"Wang","year":"2003","journal-title":"Chin Med J."},{"key":"B132","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0167-5699(88)91282-0","article-title":"Autoimmune myocarditis: a paradigm of post-infection autoimmune disease","volume":"9","author":"Rose","year":"1988","journal-title":"Immunol Today."},{"key":"B133","doi-asserted-by":"publisher","first-page":"e1008737","DOI":"10.1371\/journal.ppat.1008737","article-title":"Interplay between SARS-CoV-2 and the type I interferon response","volume":"16","author":"Sa Ribero","year":"2020","journal-title":"PLoS Pathog."},{"key":"B134","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2147\/VHRM.S5306","article-title":"The utility of troponin measurement to detect myocardial infarction: review of the current findings","volume":"6","author":"Daubert","year":"2010","journal-title":"Vasc Health Risk Manag."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/ijms20081820","article-title":"BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine","volume":"20","author":"Cao","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. Children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1182\/blood-2005-02-0456","article-title":"IL-6 blocks a discrete early step in lymphopoiesis","volume":"106","author":"Maeda","year":"2005","journal-title":"Blood."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1002\/art.41454.","article-title":"American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02834.x","article-title":"Clinical uses of intravenous immunoglobulin","volume":"142","author":"Jolles","year":"2005","journal-title":"Clin Exp Immunol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3389\/fimmu.2017.00697","article-title":"Modulatory effects of antibody replacement therapy to innate and adaptive immune cells","volume":"8","author":"Quinti","year":"2017","journal-title":"Front Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1586\/1744666X.2015.1044980","article-title":"The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease","volume":"11","author":"Burns","year":"2015","journal-title":"Expert Rev Clin Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1039\/c1fo10128e","article-title":"Natural salicylates: foods, functions and disease prevention","volume":"2","author":"Duthie","year":"2011","journal-title":"Food Funct."},{"key":"B143","doi-asserted-by":"publisher","first-page":"173124","DOI":"10.1155\/2012\/173124","article-title":"Aspirin: pharmacology and clinical applications","volume":"2012","author":"Paez Espinosa","year":"2012","journal-title":"Thrombosis."},{"key":"B144","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jsha.2019.07.002","article-title":"Acute rheumatic fever diagnosis and management: review of the global implications of the new revised diagnostic criteria with a focus on Saudi Arabia","volume":"31","author":"Alqanatish","year":"2019","journal-title":"J Saudi Heart Assoc."},{"key":"B145","first-page":"607","article-title":"Acetylsalicylic acid for children with Kawasaki disease","volume":"63","author":"Sakulchit","year":"2017","journal-title":"Can Fam Physician."},{"key":"B146","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4187\/respcare.06314","article-title":"Clinical pharmacology of corticosteroids","volume":"63","author":"Williams","year":"2018","journal-title":"Respir Care."},{"key":"B147","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1124\/mi.2.1.22","article-title":"Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies","volume":"2","author":"D'Acquisto","year":"2002","journal-title":"Mol Interv."},{"key":"B148","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/ijms20020444","article-title":"Clinical use and molecular action of corticosteroids in the pediatric age","volume":"20","author":"Ferrara","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.bcp.2012.02.006","article-title":"Prednisolone exerts exquisite inhibitory properties on platelet functions","volume":"83","author":"Liverani","year":"2012","journal-title":"Biochem Pharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"416","DOI":"10.5694\/mja2.50577","article-title":"Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)","volume":"212","author":"Zha","year":"2020","journal-title":"Med J Aust."},{"key":"B151","doi-asserted-by":"publisher","first-page":"CD011188","DOI":"10.1002\/14651858.CD011188.pub2","article-title":"Corticosteroids for the treatment of Kawasaki disease in children","volume":"1","author":"Wardle","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report","author":"Group","year":"2020","journal-title":"N Engl J Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"m3379","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for covid-19","volume":"370","author":"Lamontagne","year":"2020","journal-title":"BMJ."},{"key":"B154","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/pch\/17.3.147","article-title":"Biologic response modifiers to decrease inflammation: focus on infection risks","volume":"17","author":"Le Saux","year":"2012","journal-title":"Paediatr Child Health."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3389\/fphar.2018.01157","article-title":"Anakinra therapy for non-cancer inflammatory diseases","volume":"9","author":"Cavalli","year":"2018","journal-title":"Front Pharmacol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1136\/annrheumdis-2012-201658","article-title":"A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation","volume":"71","author":"Cohen","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1546-0096-9-21","article-title":"Partial response to anakinra in life-threatening Henoch-Schonlein purpura: case report","volume":"9","author":"Boyer","year":"2011","journal-title":"Pediatr Rheumatol Online J."},{"key":"B158","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/cei.13314","article-title":"IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis","volume":"198","author":"Gorelik","year":"2019","journal-title":"Clin Exp Immunol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2020.1755417","article-title":"Off-Label studies on anakinra in dermatology: a review","author":"Tegtmeyer","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"B160","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/2050-6511-14-40","article-title":"Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes","volume":"14","author":"Urien","year":"2013","journal-title":"BMC Pharmacol Toxicol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/acr2.11140","article-title":"Intravenous anakinra for macrophage activation syndrome may hold lessons for treatment of cytokine storm in the setting of coronavirus disease 2019","volume":"2","author":"Wampler Muskardin","year":"2020","journal-title":"ACR Open Rheumatol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (Actemra)","volume":"13","author":"Sheppard","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"B164","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-020-00342-z","article-title":"IL-6 inhibitors in the treatment of serious COVID-19: a promising therapy?","author":"Atal","year":"2020","journal-title":"Pharmaceut Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.pcl.2018.04.005","article-title":"Systemic juvenile idiopathic arthritis","volume":"65","author":"Lee","year":"2018","journal-title":"Pediatr Clin North Am."},{"key":"B167","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect."},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.6615","article-title":"Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial","author":"Salvarani","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMc1709609","article-title":"Coronary-artery aneurysm in tocilizumab-treated children with Kawasaki's Disease","volume":"377","author":"Nozawa","year":"2017","journal-title":"N Engl J Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-alpha signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit Rev Eukaryot Gene Expr."},{"key":"B171","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/MPG.0000000000002809","article-title":"Pediatric crohn's disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 treated with infliximab","volume":"71","author":"Dolinger","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B172","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.626182\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T04:58:16Z","timestamp":1697518696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.626182\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":172,"alternative-id":["10.3389\/fped.2020.626182"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.626182","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,16]]},"article-number":"626182"}}